Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Biological target proves disappointing in IPF.

Burki TK.

Lancet Respir Med. 2013 Jun;1(4):289. doi: 10.1016/S2213-2600(13)70111-5. Epub 2013 Jun 4. No abstract available.

PMID:
24429150
[PubMed - indexed for MEDLINE]
2.

Summaries for patients. Treatment of idiopathic pulmonary fibrosis with ambrisentan.

[No authors listed]

Ann Intern Med. 2013 May 7;158(9):I-32. No abstract available.

PMID:
23785719
[PubMed - indexed for MEDLINE]
3.

Endothelin receptor antagonists as disease modifiers in systemic sclerosis.

Shetty N, Derk CT.

Inflamm Allergy Drug Targets. 2011 Feb;10(1):19-26. Review.

PMID:
21184655
[PubMed - indexed for MEDLINE]
4.

Transitioning between endothelin receptor blockers: monitoring to ensure a smooth transition.

Luo N, Ryan JJ.

Can J Cardiol. 2013 Jun;29(6):659-61. doi: 10.1016/j.cjca.2012.07.006. Epub 2012 Sep 15. No abstract available.

PMID:
22985784
[PubMed - indexed for MEDLINE]
5.

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.

Raghu G, Behr J, Brown KK, Egan JJ, Kawut SM, Flaherty KR, Martinez FJ, Nathan SD, Wells AU, Collard HR, Costabel U, Richeldi L, de Andrade J, Khalil N, Morrison LD, Lederer DJ, Shao L, Li X, Pedersen PS, Montgomery AB, Chien JW, O'Riordan TG; ARTEMIS-IPF Investigators*.

Ann Intern Med. 2013 May 7;158(9):641-9. doi: 10.7326/0003-4819-158-9-201305070-00003. Erratum in: Ann Intern Med. 2014 May 6;160(9):658.

PMID:
23648946
[PubMed - indexed for MEDLINE]
6.

Ambrisentan (Letairis) for pulmonary arterial hypertension.

[No authors listed]

Med Lett Drugs Ther. 2007 Oct 22;49(1272):87-8. Review. No abstract available.

PMID:
17938611
[PubMed - indexed for MEDLINE]
7.

Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.

Langleben D.

Clin Chest Med. 2007 Mar;28(1):117-25, viii. Review.

PMID:
17338931
[PubMed - indexed for MEDLINE]
8.

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension.

Steiner MK, Preston IR.

Vasc Health Risk Manag. 2008;4(5):943-52. Review.

PMID:
19183742
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Pulmonary arterial hypertension in connective tissue diseases.

Goldberg A.

Cardiol Rev. 2010 Mar-Apr;18(2):85-8. doi: 10.1097/CRD.0b013e3181cbcde7. Review.

PMID:
20160534
[PubMed - indexed for MEDLINE]
10.

[Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].

Montani D, Humbert M.

Rev Mal Respir. 2010 Feb;27(2):103-5. doi: 10.1016/j.rmr.2009.12.007. Epub 2010 Jan 25. French. No abstract available.

PMID:
20206056
[PubMed - indexed for MEDLINE]
11.

New drug approved for pulmonary arterial hypertension.

Young D.

Am J Health Syst Pharm. 2007 Aug 1;64(15):1562. No abstract available.

PMID:
17646553
[PubMed - indexed for MEDLINE]
12.

Ambrisentan.

Newman JH, Kar S, Kirkpatrick P.

Nat Rev Drug Discov. 2007 Sep;6(9):697-8. No abstract available.

PMID:
17907344
[PubMed - indexed for MEDLINE]
13.

The status of pulmonary arterial hypertension in 2008.

Farber HW.

Circulation. 2008 Jun 10;117(23):2966-8. doi: 10.1161/CIRCULATIONAHA.108.782979. No abstract available.

PMID:
18541751
[PubMed - indexed for MEDLINE]
Free Article
14.

Sildenafil in idiopathic pulmonary fibrosis.

Maher TM.

N Engl J Med. 2010 Nov 25;363(22):2169; author reply 2170-1. doi: 10.1056/NEJMc1010408#SA1. No abstract available.

PMID:
21105804
[PubMed - indexed for MEDLINE]
15.
16.

[Treatment of pulmonary arterial hypertension: endothelin-receptor antagonists].

Hoeper MM.

Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S308-10. Review. German.

PMID:
17139593
[PubMed - indexed for MEDLINE]
17.

Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases.

Humbert M, Simonneau G.

Nat Clin Pract Rheumatol. 2005 Dec;1(2):93-101. Review.

PMID:
16932638
[PubMed - indexed for MEDLINE]
18.

Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis.

Ventetuolo CE, Kawut SM, Lederer DJ.

Respiration. 2012;84(4):299-305. Epub 2012 Aug 3.

PMID:
22869459
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A review of pulmonary arterial hypertension: role of ambrisentan.

Barst RJ.

Vasc Health Risk Manag. 2007;3(1):11-22. Review.

PMID:
17583171
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Endothelin receptor antagonists in pulmonary arterial hypertension.

Dupuis J, Hoeper MM.

Eur Respir J. 2008 Feb;31(2):407-15. doi: 10.1183/09031936.00078207. Review.

PMID:
18238950
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk